Showing 1 - 20 results of 66,799 for search '(( significant side decrease ) OR ( significant clinical diseases ))', query time: 1.00s Refine Results
  1. 1

    The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... by Yuki Oichi (11840776)

    Published 2021
    “…<p>(A) shows the carotid canal area compared between the affected side and the unaffected side in patients with unilateral moyamoya disease, and the unaffected side is significantly wider than the affected side (p = 0.018). …”
  2. 2

    Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

    Published 2023
    “…Differences between outcome groups were tested using the non-parametric Mann Whitney U test and FDR correcting for multiple testing with Benjamini-Hochberg procedure two-sided. P-values < 0.05 are statistically significant. …”
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities by Yun Zhang (131894)

    Published 2023
    “…Whether interstitial lung disease (ILD) and bronchiectasis (BE) are disease manifestations of MPA, preexisting comorbidities or important complications remains unclear. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Statistical significance of mean clinical disease score when the control group is compared to an infection dose. by Meghan E. Hermance (8771882)

    Published 2020
    “…<p>Statistically significant differences in mean clinical disease scores were compared by a one-way ANOVA followed by Dunnett’s multiple comparisons test to compare the infection doses to the control group.…”
  17. 17
  18. 18

    Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

    Published 2020
    “…Results demonstrate that TPP derivatives decrease melanoma cell viability and clonogenic survival; and there is a structure-activity relationship between TPP side chain length and decreased viability and clonogenic survival.…”
  19. 19
  20. 20